Medical News

RSS

AGBT meeting: Study workshop on complete genome sequencing for human disease

Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it will be unveiling some of its highly anticipated customer results at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., Feb. 24-27, 2010.

18 Feb 2010

NPG becomes official media partner to the 2010 WIN Symposium

Nature Publishing Group (NPG) is the official media partner to the 2010 WIN (Worldwide Innovative Networking) Symposium, it was announced today. The second annual WIN Symposium, which will be held in the Palais des Congrès, Paris, 7–9 July 2010, will bring together hundreds of oncology researchers from around the world to discuss how best to tailor therapies for patients with cancer.

18 Feb 2010

AutoGenomics awarded ISO 13485 certification for quality management system

AutoGenomics, a leader in providing automated, molecular testing solutions announced today that the organization has been awarded the ISO 13485 certification in recognition of its outstanding quality management system throughout the organization. TUV SUD America Inc. was the Certification Body.

18 Feb 2010

Single microRNA exhibits potential to forecast outcomes of MPM

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that the results of a joint study with the NYU Langone Medical Center were published online on February 16th, 2010, and are set to be published in the March 1st issue of the American Association for Cancer Research’s journal, Cancer Research.

18 Feb 2010

Spectranetics fourth-quarter revenues rise up 11%

Spectranetics Corporation today reported financial results for the quarter and full year ended December 31, 2009.

18 Feb 2010

BPA has no effects on brain development: New study

This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.

18 Feb 2010

LabCorp acquires partnership units from noncontrolling interest holder in Ontario, Canada joint venture

Laboratory Corporation of America® Holdings announced today that on February 8, 2010 it completed a transaction to acquire the partnership units from the holder of the noncontrolling interest in the Company’s Ontario, Canada joint venture in accordance with the terms of the joint venture’s partnership agreement.

18 Feb 2010

Vertebroplasty effective in treatment of VCFs

The results of a study of more than 4500 patients from six Italian EVEREST (European Vertebroplasty Research Team) Centers (Dr. G.C. Anselmetti-Candiolo Torino, Dr. G. Bonaldi-Bergamo, Dr. P. Carpeggiani-Pisa, Dr. S. Masala-Roma, Dr. M. Muto-Napoli,) confirms the effectiveness of vertebroplasty in treating vertebral compression fractures (VCFs), finding that the procedure provides significant and sustained pain relief.

18 Feb 2010

HHS Secretary to address on health disparities at NABJ conference

Secretary of Health and Human Services Kathleen Sebelius will deliver the keynote address at the National Association of Black Journalists annual conference on Health Disparities, March 4-6, 2010 at the Barbara Jordan Conference Center, Kaiser Family Foundation, 1330 G. Street, NW, Washington, D.C.

18 Feb 2010

Portico Systems, SDI announce new partnership to improve health plans

Portico Systems, the leader in Integrated Provider Management (IPM) solutions, and SDI, a leader in healthcare informatics, are announcing a new partnership. This partnership will integrate Portico’s provider management platform with SDI’s extensive provider data and managed care analytics to enable health plans to intelligently target providers for recruitment, enhance provider performance management programs, and increase decision support to members via enhanced provider profiles.

18 Feb 2010

La Pitie hospital performs 200 implants of SynCardia temporary CardioWest Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced that Groupe hospitalier de la Pitié-Salpétrière (La Pitié) in Paris has performed 200 implants of the Total Artificial Heart, more than any other hospital in the world.

18 Feb 2010

UCSF receives $1.15M grant to integrate family planning into HIV treatment and care

UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.

18 Feb 2010

Patient-centered medical home concept to benefit pharmaceutical industry

HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that the pharmaceutical industry stands to gain from the patient-centered medical home concept that continues to gain traction across the country. According to the recent New England Health Plan Analysis, medical home projects seek to maintain costs and improve health through better treatment compliance, including prescription drug regimens.

18 Feb 2010

V-Day to host three benefit productions of The Vagina Monologues as part of global violence against women

Ottawa V-Day, part of a global campaign to end violence against women and girls, will host three benefit productions of The Vagina Monologues on Friday, February 26 and Saturday, February 27 at the National Gallery of Canada.

18 Feb 2010

Norwegian government task force suggests formation of single company to commercialise biomaterial assets

Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country’s various sources. The task force has also recommended HUNT Biosciences be a model for the national company.

18 Feb 2010

Home palliative care: A major strategy to improve end-of-life care in UK NHS

Time and again, in every part of the world, surveys show that people with life-threatening illness want to spend as much of the time that is left at home, rather than in hospital. They aspire to die in their own surroundings, peacefully and pain free. Increasingly, clinicians, managers and commissioners of health services are recognising this and building services to meet it. In the UK NHS, it has become part of a major strategy to improve end-of-life care.

18 Feb 2010

URAC to conduct workshop highlighting multiple aspects of medication adherence

URAC, the nation's leading health care accreditation and education organization, will conduct a workshop on "Medication Adherence and Medication Possession Ratio as a Critical Metric" at the 15th Annual Pharmacy Benefit Management Institute (PBMI) Conference in Phoenix, Ariz.

18 Feb 2010

Biotage announces global launch of Syro Wave microwave and parallel peptide synthesizer

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.

18 Feb 2010

Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer's disease, a combination therapy that delays nursing home admission at 19 months would earn 43 percent patient share, according to surveyed U.S. neurologists. In comparison, in Europe, such an agent would earn a slightly lower patient share of 30 percent, according to surveyed European neurologists. This lower share estimate is possibly a result of higher price sensitivity of European markets.

18 Feb 2010

Clarion Care develops healthcare software solution to reduce deficit by 42%

As Washington state government considers difficult tax increases and searches for ways to cut spending, Clarion Care, an innovative company, has developed a healthcare software solution that can reduce the deficit by 42%.

18 Feb 2010